Question 1

Does Frontier Capital Management own KPTI stock?

Accepted Answer

No. Frontier Capital Management exited its KPTI (Karyopharm Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 629,154 shares worth $3.4M.

Question 2

How many shares of KPTI does Frontier Capital Management own?

Accepted Answer

None since Q4 2022, when Frontier Capital Management exited the position. Its Q3 2022 13F listed 629,154 shares worth $3.4M.

Question 3

What is Frontier Capital Management's KPTI position worth?

Accepted Answer

Frontier Capital Management's KPTI position was worth $3.4M in its Q3 2022 13F, before the exit in Q4 2022.

Question 4

Is Frontier Capital Management buying or selling KPTI?

Accepted Answer

In Q4 2022, Frontier Capital Management exited its entire KPTI position.

Question 5

When did Frontier Capital Management first buy KPTI?

Accepted Answer

Frontier Capital Management already held KPTI in its Q1 2019 13F, the earliest on record, and listed it in 15 quarterly 13F filings.